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Preface
Someone told me “a PhD thesis is just like a story”. From my viewpoint, the story
formed the major part of my past six-year life, and they will significantly affect my
future research career and even my whole life. I tried to make the story something
that would be interesting and useful to be read. On the other hand, I tried to cut its
length to save the possible readers precious time.
As a PhD student, besides to master or to learn the techniques and methodologies
as a Master student or a technician, to think about the philosophy or to explain the
findings (including that of the others besides myself) would be also or even more
important for the future related research fields. You would find the thesis in some
extent (in particular, in section 3) reflected the above considerations.
From the teacher side, the selection of good teachers would be very important for a
good student. I was so lucky to be a student of Professors Lyn Gilbert and Tania
Sorrell. I also want to thank so many “informal teachers”, I may only know many of
them from their excellent publications (I tried my best to include their contributions
in my reference sections though I might still have lost many for cutting the volume
reason), and these teachers are also highly appreciated. Molecular lab – I located
myself there in my past six years, all the staffs there were so kind and the conditions
there were so good – the experience there will be kept in my mind as a very
memorable life in my personal history.
The two tiny microorganisms that I selected, as my study objectives – GBS and
ureaplasmas – were also my very great teachers! They showed me that they also
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in section 3) but far from enough. No doubt, their “wisdom” deserves to be further
studied – especially based on their invaluable genome resources and benefit from
the new bioinformatic concepts, theory and research tools.
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The thesis contains three sections. The first section of general introduction provided
the background and some useful concepts of the next two sections. The second
section mainly contained those so called “traditional” molecular microbiology
study of the two microorganisms. It included mainly the genotyping studies, which
included most of my previous publications (also see appendices). My past six year
publications (in PDF format) had been used as appendices and were put at the end
of the thesis. Their inner relationship was also given at the beginning of the
appendices. So only selected parts (after modification and reorganization) that were
believed to be important to explain the outline of the story were put into the body of
the thesis (mainly in section 2).   The third section of the thesis contained some so
called “novel” genomic and bioinformatics based study of the two organisms.
Because we are facing the dramatic paradigm shift in their post genomic era, the
ideas contained in the study may not be absolutely correct; even for the correct ones,
some of them may still look a little bit ugly. But at least I would like to use them to
show the potential values for doing this kind of “novel” study.
It was not easy to be a PhD student, especially considering the era of knowledge
explosion, and the so many paradigm shifts. In this case, I really feel that what I had
done was far from enough. However, to get the PhD or to pass the milestone is my
long-term dream (even from my early childhood). So could I dare to use this thesis
to have a try?
If the thesis can be seen as a very tiny drop of but useful water comparing with the
endless sea of the truth, I will be more than happy!
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Abstract
Group B streptococcus (GBS, S. agalactiae) and human ureaplasmas (U. parvum
and U. urealyticum) are two clinically and phylogenetically related, potential
perinatal pathogens. Their relationships between genotypes and pathogenesis of
GBS and ureaplasma infection were still not well understood, one of the reason is
that both of them are still short of a very practical genotyping system. In the study,
to solve the above problem we developed genotyping systems for the organisms (the
second section). For human ureaplasmas, based on four genes/gene clusters (rRNA
gene clusters, the elongation factor Tu genes, urease gene complexes and multiple
banded antigen genes), we designed many primer pairs suitable for developing
species identification assays for the two newly established human ureaplasma
species (U. parvum and U. urealyticum). Further, based on the heterogeneity of
ureaplasma multiple banded antigen gene (which contains species- and serovar-
specific regions), we developed genotyping methods for each ureaplasma species.
For GBS, based on three sets of molecular markers (capsular polysaccharide
synthesis gene clusters, surface protein antigen genes and mobile genetic elements),
we developed a genotyping system. The primary evaluation of the genotyping
systems showed that the genotyping systems were practical alternative assays for
the conventional serotyping and they will be useful to further explore the
relationships between genotypes and pathogenesis of GBS and ureaplasma
infection. In the study, we introduced novel data and tools into GBS and ureaplasma
studies especially from genomic- and bioinformatics-based molecular microbiology
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(the third section). For two newly established human ureaplasma species, based on
the U. parvum serovar-3 genome, and using the above four important genes/gene
clusters, we exposed some interesting problems in the understanding of new
ureaplasma taxonomy especially in the post genomic era. For GBS, we studied the
two published full genomes and exposed some new problems or possible future new
research fields. In particular we found the two finished and one ongoing GBS
genomes were all non-typical and suggest that future genomic project had better
have genetic population structure viewpoint. Finally, we suggested that integrated
studies of the two potential or conditional perinatal pathogens, from the viewpoint
of evolution, would provide a new understanding angle of the pathogenesis of the
two organisms. Studies suggested that during coevolution, human ureaplasmas
(especially U. parvum) became friendlier than their ancestors to their human host
(by losing most of its virulence genes); however, GBS tried to increase its invasive
abilities (by getting more virulence genes) to fight against the human host attack.
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